Warburg Pincus and Mubadala Acquire Pharma Intelligence from Informa

June 1, 2022

Warburg Pincus, joined by Mubadala Investment Company, completed the acquisition of Pharma Intelligence (the Citeline suite and related specialist brands) from Informa PLC, with Informa retaining a 15% equity stake. The investors said they will invest in product development and innovation to expand Pharma Intelligence's position in the pharmaceutical data and analytics market; Jay Nadler was appointed Executive Chair following completion.

Buyers
Warburg Pincus, Mubadala Investment Company
Targets
Pharma Intelligence
Sellers
Informa PLC
Industry
Data & Analytics
Location
England, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.